BioCentury | Jan 20, 2017
Clinical News

Stanford team reports live imaging of CAR T cells

...T cells engage tumor cells. He cited proof-of-concept animal studies that have validated the approach. CellCyte Genetics Corp....
BioCentury | Oct 4, 2010
Company News

CellCyte management update

CellCyte Genetics Corp. (OTCBB:CCYG), Bellevue, Wash. Business: Gene/Cell therapy Transitioned: Douglas Pat Cerretti to president in July, while remaining CSO and director of business development WIR Staff...
BioCentury | Nov 16, 2009
Company News

CellCyte management update

CellCyte Genetics Corp. (OTCBB:CCYG), Bellevue, Wash. Business: Gene/Cell therapy Hired: Douglas Cerretti as CSO and director of business development, formerly scientific director at Amgen Inc.; he replaces Ron Berninger, who resigned WIR Staff...
BioCentury | Sep 14, 2009
Company News

CellCyte gene/cell therapy news

...filed two suits in the U.S. District Court for the Western District of Washington against CellCyte...
...former CEO Gary Reys is charged with violating SEC antifraud provisions and aiding and abetting CellCyte's...
...an order barring Reys from serving as an officer or director of a public company. CellCyte Genetics Corp....
BioCentury | May 25, 2009
Finance

Stem cell stocks

...$2.88 2% 3% NeoStem Inc. (NYSE-A:NBS) $1.98 2% 5% Athersys Inc. (NASDAQ:ATHX) $0.89 0% 9% Cellcyte Genetics Corp....
BioCentury | Jul 14, 2008
Company News

CellCyte gene/cell therapy news

...marrow-derived stem cells. The company said that InCap also will advise it on future financings. CellCyte Genetics Corp....
BioCentury | May 26, 2008
Company News

CellCyte scientific advisory board update

CellCyte Genetics Corp. (OTCBB:CCYG), Bothell, Wash. Business: Gene/Cell therapy Appointed: Jay Traverse, associate professor of medicine at the University of Minnesota WIR Staff...
BioCentury | Jun 4, 2007
Company News

CellCyte management update

CellCyte Genetics Corp. (CCYG), Kirkland, Wash. Business: Gene/Cell therapy Hired: Mark Reys as VP of operations WIR Staff...
BioCentury | May 21, 2007
Company News

CellCyte gene/cell therapy news

...CCYG will move its headquarters to Bothell, Wash., in September. CellCyte Genetics Corp. (CCYG), Kirkland, Wash. Business: Gene/Cell...
BioCentury | May 14, 2007
Company News

CellCyte management update

CellCyte Genetics Corp. (CCYG), Kirkland, Wash. Business: Gene/Cell therapy Hired: Nathan McDonald as VP of finance, formerly managing partner at Venture Velocity WIR Staff...
Items per page:
1 - 10 of 11
BioCentury | Jan 20, 2017
Clinical News

Stanford team reports live imaging of CAR T cells

...T cells engage tumor cells. He cited proof-of-concept animal studies that have validated the approach. CellCyte Genetics Corp....
BioCentury | Oct 4, 2010
Company News

CellCyte management update

CellCyte Genetics Corp. (OTCBB:CCYG), Bellevue, Wash. Business: Gene/Cell therapy Transitioned: Douglas Pat Cerretti to president in July, while remaining CSO and director of business development WIR Staff...
BioCentury | Nov 16, 2009
Company News

CellCyte management update

CellCyte Genetics Corp. (OTCBB:CCYG), Bellevue, Wash. Business: Gene/Cell therapy Hired: Douglas Cerretti as CSO and director of business development, formerly scientific director at Amgen Inc.; he replaces Ron Berninger, who resigned WIR Staff...
BioCentury | Sep 14, 2009
Company News

CellCyte gene/cell therapy news

...filed two suits in the U.S. District Court for the Western District of Washington against CellCyte...
...former CEO Gary Reys is charged with violating SEC antifraud provisions and aiding and abetting CellCyte's...
...an order barring Reys from serving as an officer or director of a public company. CellCyte Genetics Corp....
BioCentury | May 25, 2009
Finance

Stem cell stocks

...$2.88 2% 3% NeoStem Inc. (NYSE-A:NBS) $1.98 2% 5% Athersys Inc. (NASDAQ:ATHX) $0.89 0% 9% Cellcyte Genetics Corp....
BioCentury | Jul 14, 2008
Company News

CellCyte gene/cell therapy news

...marrow-derived stem cells. The company said that InCap also will advise it on future financings. CellCyte Genetics Corp....
BioCentury | May 26, 2008
Company News

CellCyte scientific advisory board update

CellCyte Genetics Corp. (OTCBB:CCYG), Bothell, Wash. Business: Gene/Cell therapy Appointed: Jay Traverse, associate professor of medicine at the University of Minnesota WIR Staff...
BioCentury | Jun 4, 2007
Company News

CellCyte management update

CellCyte Genetics Corp. (CCYG), Kirkland, Wash. Business: Gene/Cell therapy Hired: Mark Reys as VP of operations WIR Staff...
BioCentury | May 21, 2007
Company News

CellCyte gene/cell therapy news

...CCYG will move its headquarters to Bothell, Wash., in September. CellCyte Genetics Corp. (CCYG), Kirkland, Wash. Business: Gene/Cell...
BioCentury | May 14, 2007
Company News

CellCyte management update

CellCyte Genetics Corp. (CCYG), Kirkland, Wash. Business: Gene/Cell therapy Hired: Nathan McDonald as VP of finance, formerly managing partner at Venture Velocity WIR Staff...
Items per page:
1 - 10 of 11